Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-048861
Filing Date
2019-09-09
Accepted
2019-09-09 13:48:51
Documents
1
Period of Report
2019-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7403
  Complete submission text file 0001209191-19-048861.txt   9078
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address 20725 S. WESTERN BLVD. SUITE 136 TORRANCE CA 90501
Business Address
Niihara Yutaka (Reporting) CIK: 0001517691 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35527 | Film No.: 191082801